Accel Entertainment (ACEL) Form 144 Discloses 12,500-Share Sale via Morgan Stanley

Rhea-AI Filing Summary

Form 144 filed for Accel Entertainment, Inc. (ACEL) reporting a proposed sale of 12,500 common shares through Morgan Stanley Smith Barney with an aggregate market value of $139,125. The filing lists the approximate date of sale as 09/15/2025 and shows 84,293,802 shares outstanding. The shares were originally acquired on 07/01/2013 in a SPAC transaction, and payment was recorded as of that date. The notice also discloses recent executed sales over the past three months: six 10b5-1 sales of 12,500 shares each on 06/16/2025, 07/15/2025 and 08/15/2025 for two accounts (Grant Place Fund LLC and Crilly Court Trust), resulting in gross proceeds ranging from $138,753.75 to $151,186.25. The filer certifies no undisclosed material adverse information and references Rule 10b5-1 where applicable.

Positive

• Broker identified (Morgan Stanley Smith Barney), providing a clear execution channel for the sale
• Acquisition history disclosed: shares acquired 07/01/2013 via SPAC transaction
• Recent 10b5-1 sales disclosed, indicating prearranged trading plans and transparency for insider transactions

Negative

• Significant executed volume in past 3 months: six sales of 12,500 shares each (total 75,000 shares) reported, with gross proceeds disclosed
• Proposed sale on public market (12,500 shares) will further add to recent insider sales

Insights

Securities Analyst

TL;DR: Routine Form 144 reporting a small block sale and recent 10b5-1 executions; no new financial results disclosed.

The filing documents a proposed public sale of 12,500 common shares through Morgan Stanley Smith Barney with an aggregate market value of $139,125 and identifies the securities as originally acquired in a SPAC transaction on 07/01/2013. It also provides explicit transactional history showing six 10b5-1 sales of 12,500 shares each in June, July and August 2025 across two accounts, with gross proceeds reported per trade. From a market-impact perspective, the disclosure is procedural and supplies necessary transferability and insider-sale transparency but does not present new operating or earnings information.

Compliance / Risk Analyst

TL;DR: Filing appears compliant with Rule 144 and notes use of 10b5-1 plans; filer attests no undisclosed material adverse information.

The Form 144 lists broker details, acquisition date, and the nature of acquisition (SPAC), and includes a signature representation regarding material information and a reference to Rule 10b5-1 plan adoption or instructions. The document explicitly enumerates recent 10b5-1 sales and gross proceeds, which supports traceability and compliance. There are no statements of material adverse events or unusual payment arrangements; the filing is procedural and aligned with disclosure obligations for prearranged insider sales.

FAQ

What does the Form 144 for ACEL report?

The Form 144 reports a proposed sale of 12,500 common shares with aggregate market value $139,125, to be sold via Morgan Stanley Smith Barney.

When is the approximate date of the proposed sale?

The filing lists the approximate date of sale as 09/15/2025.

How and when were the shares originally acquired?

The shares were acquired on 07/01/2013 in a SPAC transaction.

Were there recent sales of the issuer's shares by the filer?

Yes. The filing discloses six 10b5-1 sales of 12,500 shares each on 06/16/2025, 07/15/2025, and 08/15/2025 across two accounts, totaling 75,000 shares.

How many shares outstanding does the filing report?

The filing reports 84,293,802 shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/15/2025 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	12500	139125.00	84293802	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2013	SPAC Transaction	Issuer			12500	07/01/2013	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for GRANT PLACE FUND LLC 140 Tower Drive Burr Ridge IL 60527	Common	08/15/2025	12500	138753.75
10b5-1 Sales for CRILLY COURT TRUST 140 Tower Drive Burr Ridge IL 60527	Common	08/15/2025	12500	138753.75
10b5-1 Sales for GRANT PLACE FUND LLC 140 Tower Drive Burr Ridge IL 60527	Common	07/15/2025	12500	151186.25
10b5-1 Sales for CRILLY COURT TRUST 140 Tower Drive Burr Ridge IL 60527	Common	07/15/2025	12500	151171.25
10b5-1 Sales for GRANT PLACE FUND LLC 140 Tower Drive Burr Ridge IL 60527	Common	06/16/2025	12500	141232.50
10b5-1 Sales for CRILLY COURT TRUST 140 Tower Drive Burr Ridge IL 60527	Common	06/16/2025	12500	141232.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)